Ef5
Clinical Trials Overview
1 trials found
About Ef5
Ef5 is currently under investigation for use in metastatic colorectal cancer as a targeted therapy. It has shown promising results in preclinical studies but its efficacy and safety profile are still being evaluated in clinical trials.
Category
Terapia Dirigida
Mechanism
Ef5 is an investigational agent that targets the epidermal growth factor receptor (EGFR) in colorectal cancer cells, inhibiting cell proliferation and angiogenesis.
1
Total Trials
0
Recruiting
1
Active
0
Completed
30
Total Enrollment
1
Countries
NCT00087191
Not Applicable
Active
30 patients
Medications:
Ef5
This clinical trial is studying the amount of EF5 and motexafin lutetium present in tumor cells and/or normal tissues of patients with abdominal (such as ovarian, colon, or stomach cancer) or non-small cell lung cancer. EF5 may be effective in measur...
United States